Rhinitis patients with sputum eosinophilia show decreased lung function in the absence of airway hyperresponsiveness

Allergy, Asthma and Immunology Research

Volumn 5, Issue 4, 2013, Pages 232-238

  Yang, Min Suk ^a,b   Lee, Hyun Seung ^b   Kim, Min Hye ^b   Song, Woo Jung ^b   Kim, Tae Wan ^c   Kwon, Jae Woo ^d   Kim, Sae Hoon ^b,e   Park, Heung Woo ^b   Chang, Yoon Seok ^b,e   Cho, Sang Heon ^b   Min, Kyung Up ^b  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korean Armed Forces Capital Hospital   (South Korea)

^d Kangwon National University College of Medicine   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

Author keywords

Eosinophil; Forced expiratory volume; Matrix metalloproteinase 9; Rhinitis; Sputum

Indexed keywords

GELATINASE B; MESSENGER RNA; METHACHOLINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALLERGY TEST; ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FIBROSIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; PERENNIAL RHINITIS; PROVOCATION TEST; RESPIRATORY TRACT ALLERGY; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TEST; SPIROMETRY; SPUTUM; SPUTUM ANALYSIS;

EID: 84881350006     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2013.5.4.232     Document Type: Article

References (32)

1. Ciprandi G, Cirillo I, Tosca MA, Vizzaccaro A. Bronchial hyperreactivity and spirometric impairment in polysensitized patients with allergic rhinitis. Clin Mol Allergy 2004;2:3.
2. Prieto L, Gutiérrez V, Liñana J, Marín J. Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis. Eur Respir J 2001;17:64-70.
3. Tatar M, Petriskova J, Zucha J, Pecova R, Hutka Z, Raffajova J, Brozmanova M. Induced sputum eosinophils, bronchial reactivity, and cough sensitivity in subjects with allergic rhinitis. J Physiol Pharmacol 2005;56 Suppl 4:227-36.
4. Laprise C, Boulet LP. Asymptomatic airway hyperresponsiveness: a three-year follow-up. Am J Respir Crit Care Med 1997;156:403-9.
5. Porsbjerg C, von Linstow ML, Ulrik CS, Nepper-Christensen S, Backer V. Risk factors for onset of asthma: a 12-year prospective follow-up study. Chest 2006;129:309-16.
6. Park YM, Bochner BS. Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol Res 2010;2:87-101.
7. Polosa R, Ciamarra I, Mangano G, Prosperini G, Pistorio MP, Vancheri C, Crimi N. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J 2000;15:30-5.
8. Gutiérrez V, Prieto L, Torres V, Morales C, González E. Peak flow variability and sputum eosinophilia in allergic rhinitis. Ann Allergy Asthma Immunol 1998;81:143-50.
9. Park CS. Eosinophilic bronchitis, eosinophilia associated genetic variants, and notch signaling in asthma. Allergy Asthma Immunol Res 2010;2:188-94.
10. Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. Eur Respir J 1999;14:1228-30.
11. Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q. Role of transforming growth factor-beta in airway remodeling in asthma. Am J Respir Cell Mol Biol 2011;44:127-33.
12. Ohbayashi H, Shimokata K. Matrix metalloproteinase-9 and airway remodeling in asthma. Curr Drug Targets Inflamm Allergy 2005;4:177-81.
13. Bergeron C, Tulic MK, Hamid Q. Tools used to measure airway remodelling in research. Eur Respir J 2007;29:596-604.
14. Cataldo DD, Gueders M, Munaut C, Rocks N, Bartsch P, Foidart JM, Noël A, Louis R. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest 2004;84:418-24.
15. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76.
16. Sohn SW, Lee HS, Park HW, Chang YS, Kim YK, Cho SH, Kim YY, Min KU. Evaluation of cytokine mRNA in induced sputum from patients with allergic rhinitis: relationship to airway hyperresponsiveness. Allergy 2008;63:268-73.
17. Alvarez MJ, Olaguibel JM, García BE, Rodríquez A, Tabar AI, Urbiola E. Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Allergy 2000;55:355-62.
18. Leone C, Teodoro C, Pelucchi A, Mastropasqua B, Cavigioli G, Marazzini L, Foresi A. Bronchial responsiveness and airway inflammation in patients with nonallergic rhinitis with eosinophilia syndrome. J Allergy Clin Immunol 1997;100:775-80.
19. Ciprandi G, Cirillo I. The lower airway pathology of rhinitis. J Allergy Clin Immunol 2006;118:1105-9.
20. Kessel A, Halloun H, Bamberger E, Kugelman A, Toubi E. Abnormal spirometry in children with persistent allergic rhinitis due to mite sensitization: the benefit of nasal corticosteroids. Pediatr Allergy Immunol 2008;19:61-6.
21. Brightling CE. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006;129:116S-121S.
22. Park SW, Lee YM, Jang AS, Lee JH, Hwangbo Y, Kim DJ, Park CS. Development of chronic airway obstruction in patients with eosinophilic bronchitis: a prospective follow-up study. Chest 2004;125:1998-2004.
23. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346:1699-705.
24. Chakir J, Laviolette M, Boutet M, Laliberté R, Dubé J, Boulet LP. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996;75:735-44.
25. Demedts IK, Brusselle GG, Bracke KR, Vermaelen KY, Pauwels RA. Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol 2005;5:257-63.
26. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003;28:12-24.
27. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91:97-101
28. Dahl R, Nielsen LP, Kips J, Foresi A, Cauwenberge P, Tudoric N, Howarth P, Richards DH, Williams M, Pauwels R; SPIRA Study Group. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 2005;60:875-81.
29. Orhan F, Sekerel BE, Adalioglu G, Pinar M, Tuncer A. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2004;92:438-45.
30. van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 1999;54:403-8.
31. Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 2002;122:1543-52.
32. Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, Boulet LP, Hamid Q. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003;111:1293-8.